OverviewSuggest Edit

Aethlon Medical, Inc. creates diagnostic and therapeutic device solutions for infectious disease and cancer. The Company's Aethlon ADAPT platform provides the technology foundation for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. The Aethlon ADAPT product pipeline includes the Hemopurifier, a first-in-class medical device with broad-spectrum capabilities against exosomes that contribute to the progression of cancer and infectious viral pathogens such as HIV and Hepatitis C.

TypePublic
Founded1998
HQSan Diego, US
Websiteaethlonmedical.com

Latest Updates

Employees (est.) (Mar 2018)6(-14%)
Revenue (FY, 2018)$149.6 K(-61%)
Share Price (Jun 2019)$0.4 (-5%)

Key People/Management at Aethlon Medical

James A. Joyce

James A. Joyce

Chief Executive Officer and Director
Rodney S. Kenley

Rodney S. Kenley

President
James B. Frakes

James B. Frakes

Chief Financial Officer and Senior Vice President – Finance
Michael Jacobs

Michael Jacobs

Senior Scientist
Annette Marleau

Annette Marleau

Director of Research
Show more

Aethlon Medical Office Locations

Aethlon Medical has an office in San Diego
San Diego, US (HQ)
9635 Granite Ridge Dr #100
Show all (1)

Aethlon Medical Financials and Metrics

Aethlon Medical Revenue

Aethlon Medical's revenue was reported to be $149.63 k in FY, 2018 which is a 61.8% decrease from the previous period.
USD

Revenue (FY, 2018)

149.6k

Revenue growth (FY, 2017 - FY, 2018), %

(61.8%)

Net income (FY, 2018)

(5.7m)

EBIT (FY, 2018)

(4.8m)

Market capitalization (10-Jun-2019)

6.7m

Closing stock price (10-Jun-2019)

0.4

Cash (31-Mar-2018)

7.0m

EV

522.2k
Aethlon Medical's current market capitalization is $6.7 m.
USDFY, 2015FY, 2016FY, 2017FY, 2018

Revenue

762.4k886.6k392.1k149.6k

Revenue growth, %

16%(56%)(62%)

General and administrative expense

907.1k929.0k849.5k792.6k

Operating expense total

4.8m5.3m6.5m5.0m
USDFY, 2015FY, 2016FY, 2017FY, 2018

Cash

855.6k2.1m1.6m7.0m

Accounts Receivable

193.3k199.5k74.8k

Prepaid Expenses

73.1k53.3k37.6k181.4k

Current Assets

1.2m2.4m1.6m7.2m
USDFY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(7.0m)(5.0m)(7.3m)(5.7m)

Depreciation and Amortization

37.4k38.5k32.4k35.7k

Accounts Payable

(1.1m)(46.4k)322.1k(104.2k)

Cash From Operating Activities

(5.0m)(4.3m)(3.5m)(3.9m)
USDY, 2018

EV/EBIT

0.2 x

EV/CFO

0.2 x

Revenue/Employee

24.9k

Debt/Equity

0.1 x

Debt/Assets

0.1 x

Financial Leverage

1.2 x

P/E Ratio

(0.6)
Show all financial metrics

Aethlon Medical Online and Social Media Presence

Embed Graph

Aethlon Medical News and Updates

Aethlon Medical To Release First Quarter Financial Results and Host Conference Call on August 14, 2019

SAN DIEGO, Aug. 7, 2019 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health, today announced that it will issue financial results for its first quarter fiscal year 2020, ended June 30, 2019, at 4:15pm Eastern time...

Thinking about buying stock in Aethlon Medical, Alibaba, Canopy Growth, Eros International, or Tilray?

NEW YORK, July 2, 2019 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AEMD, BABA, CGC, EROS, and TLRY. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Aethlon Medical, Inc. Announces Appointment of Lisa M. Boswell as Director, Quality Systems and Regulatory Affairs

SAN DIEGO, March 7, 2019 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic medical device company focused on addressing critical unmet needs in global health, announces the appointment of Lisa M. Boswell, to the position of Director, Quality Systems and Regulatory...

Aethlon Medical To Release Quarterly Financial Results and Host Conference Call on February 11, 2019

SAN DIEGO, Feb. 4, 2019 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health, today announced that it will issue financial results for the third quarter of fiscal year 2019, ended December 31, 2018, at 4:15 pm...

Aethlon Medical Announces Second Quarter Fiscal Year 2019 Results

SAN DIEGO, Nov. 6, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health, today announced results for its fiscal second quarter ended September 30, 2018. Second Quarter Financial Results The Company's net loss...

Aethlon Medical to Present at the NYC Oncology Conference

SAN DIEGO, Oct. 29, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq:AEMD), an immunotherapeutic technology company focused on unmet needs in global health, today announced that its CEO, Jim Joyce, will present at the NYC Oncology Investor Conference on Tuesday, October 30, 2018 at...
Show more

Aethlon Medical Frequently Asked Questions

  • When was Aethlon Medical founded?

    Aethlon Medical was founded in 1998.

  • Who are Aethlon Medical key executives?

    Aethlon Medical's key executives are James A. Joyce, Rodney S. Kenley and James B. Frakes.

  • How many employees does Aethlon Medical have?

    Aethlon Medical has 6 employees.

  • What is Aethlon Medical revenue?

    Latest Aethlon Medical annual revenue is $149.6 k.

  • What is Aethlon Medical revenue per employee?

    Latest Aethlon Medical revenue per employee is $24.9 k.

  • Who are Aethlon Medical competitors?

    Competitors of Aethlon Medical include Isoray, ICU Medical and Sensus Healthcare.

  • Where is Aethlon Medical headquarters?

    Aethlon Medical headquarters is located at 9635 Granite Ridge Dr #100, San Diego.

  • Where are Aethlon Medical offices?

    Aethlon Medical has an office in San Diego.

  • How many offices does Aethlon Medical have?

    Aethlon Medical has 1 office.